Exclusive: Merck explores $15 billion-plus drug portfolio sale - sources

NEW YORK/LONDON (Reuters) - Merck & Co Inc is looking to sell a big portfolio of mature drugs that could fetch more than $15 billion, according to people familiar with the matter, as the U.S. drugmaker continues to streamline businesses to focus on high-growth areas.

from Reuters: Business News http://ift.tt/1meMyGh